Clarify Health and Leidos Announce Strategic Alliance to Deliver Innovative Analytics Solutions to their Healthcare Partners
January 14, 2020 at 03:00 am IST
Share
Clarify Health Solutions announced a strategic alliance with Leidos that will facilitate improved healthcare operations and impact through governance-based digital solutions. Under the agreement, Leidos will enable its customers to deliver Clarify-generated observed and predictive insights directly into healthcare operations through its careC2 platform. Clarify Health Solutions has accumulated one of the large patient-level datasets in healthcare which it uses to generate observed and predictive insights by a world-class team of data scientists, engineers, clinicians, and healthcare experts. Clarify Health’s products and insights are leveraged by industry leaders across health systems, health plans, and life sciences companies to improve the value of care delivered as well as therapies offered patients. Leidos’ careC2 platform enables its customers to improve their clinical, financial, and operational results by providing a single, secure, real-time view of operations across their healthcare ecosystem in order to efficiently deliver the right services to the right patient at the right point in their health journey. careC2 provides users with the tools to design, build and commercialize their own applications to close capability gaps where they may exist and diversify revenue. Delivering Clarify Health Solutions predictive insights through the Leidos careC2 applications provides Leidos with a differentiated solution in the market, combining the power of the careC2 data services, security, compliance, and governance capabilities with Clarify’s analytics capabilities. With a joint focus on the delivery of better care through technology that can most effectively distill fractured, disparate health data into actionable insights, Clarify Health and Leidos will co-develop a roadmap to address their current and new customers’ unmet needs.
Leidos Holdings, Inc. specializes in the provision of engineering, technological and scientific services. Net sales by business segment break down as follows:
- defense (56.6%): design, engineering and integration of technological solutions for intelligence, airborne surveillance and reconnaissance, maritime and land-based solutions, electronic warfare systems, and automated sensor, alarm, command and control systems, software development, cyber security solutions and data processing and analysis solutions, IT infrastructure development and integration, etc.;
- civil security (23.7%): development and integration of solutions for the protection of goods, data and digital information, solutions and systems for air traffic flow control and flight data management, vehicle and cargo inspection, explosives and radiation detection, computer security, environmental management, nuclear security, complex logistics management, etc.;
- health (19.7%): integration of complex systems and technological infrastructures for the management of data, medical information and electronic health records, provision of healthcare services, IT systems lifecycle management, research and development of biopharmaceuticals, etc.
Net sales by market are divided between the US Department of Defense and the intelligence community (49.4%), government agencies (37.4%) and commercial customers (13.2%).
The United States accounts for 91,4% of net sales.